Deseret News
Firm to pay Utah $24 million in settlement
By Geoff Liesik
Pharmaceutical giant Eli Lilly and Co. has agreed to pay $24 million to settle a lawsuit filed by the Utah Attorney General’s Office.
Attorney General Mark Shurtleff sued the company after a nearly four-year investigation revealed that Lilly concealed its knowledge of significant weight gain [...]
Entries Tagged as ‘Uncategorized’
November 11, 2009
Eli Lilly to pay Utah $24 million in settlement
May 26, 2009
CBS Evening News – May 25, 2009 – Risperdal
“Caution: Graphic Content:” For children “diagnosed” with ADD and bi-polar disorder, Risperdal is used for “treatment”. The side effects are putting them at serious risk.
more about "Risperdal", posted with vodpod
February 27, 2009
Documents on Seroquel show drugmaker knew of risks
Associated Press
Documents on Seroquel show drugmaker knew of risks
By LINDA A. JOHNSON
TRENTON, N.J.
Internal AstraZeneca reports and e-mails written by company officials show they knew a decade ago that their psychiatric drug Seroquel caused diabetes and major weight gain, plaintiffs’ lawyers said Friday after releasing dozens of the previously sealed documents.
“They not only failed to [...]
February 25, 2009
Ruling near on privacy issues in Seroquel case
Philadelphia Inquirer
By Miriam Hill
Feb. 25, 2009
Does the world have the right to know about negative studies on AstraZeneca’s potent antipsychotic drug Seroquel?
Or whether company representatives promoted the drug for unapproved uses?
And what about details of sexual relationships between Wayne Macfadden, AstraZeneca’s former U.S. medical director for Seroquel, and two women who researched and wrote [...]
February 20, 2009
Seroquel suit in Arkansas to proceed
Arkansas Democrat-Gazette (Little Rock)
State drug suit gains court go-ahead McDaniel contends manufacturer’s misinformation proved costly
BY CAROLYNE PARK
The state’s lawsuit against drug manufacturer AstraZeneca will move forward after a judge ruled Thursday against the company’s motion to dismiss the case.
In its complaint filed by Arkansas Attorney General Dustin McDaniel last May, the state claims AstraZeneca gave [...]
February 15, 2009
Seroquel maker wants to seal info from you, “for” you
St. Petersburg Times
Seroquel maker wants to seal info from you, “for” you
By Kris Hundley
In Print: Sunday, February 15, 2009
AstraZeneca, maker of the blockbuster antipsychotic Seroquel, is battling to keep information about the drug out of the public’s view … for the public’s own good.
Later this month in Orlando, lawyers for the drugmaker will argue [...]
January 23, 2009
Marketing a Phony “Miracle” Drug – Zyprexa
Rolling Stone
SPECIAL REPORT
Marketing a Phony “Miracle” Drug
By Ben Wallace-Wells
Zyprexa was created to treat schizophrenia, but it wound up being used on depressed moms and misbehaving kids. How one of the nation’s biggest pharmaceutical companies turned a flawed, dangerous pill into a multi-billion-dollar bonanza — and who paid the price.
January 19, 2009
Whistle-blower’s perspective on Lilly case
Philadelphia Inquirer
Whistle-blower’s perspective on Lilly case
By Miriam Hill
Robert Rudolph knew he was about to end his lucrative career at Eli Lilly & Co., but he had to say something.
Why, he asked management, was the Indianapolis pharmaceutical company marketing its antipsychotic drug Zyprexa to elderly people when the drug was not approved for that [...]
January 15, 2009
Lilly Reaches Zyprexa Settlement
Wall Street Journal
Lilly Reaches Zyprexa Settlement
By KERRY E. GRACE
Eli Lilly & Co. agreed to pay $1.42 billion in a long-awaited settlement with federal prosecutors regarding allegations of improperly marketing its blockbuster antipsychotic drug Zyprexa.
A resolution has been expected since October, when the Indianapolis drug maker announced it was in “advanced discussions” and had set [...]
January 15, 2009
LILLY TO PAY RECORD $1.415 BILLION FOR OFF-LABEL DRUG MARKETING
U.S. Department of Justice
United States Attorney
Eastern District of Pennsylvania
615 Chestnut Street
Suite 1250
Philadelphia, Pennsylvania 19106-4476
(215) 861-8200
For Immediate Release January 15, 2009
PHARMACEUTICAL COMPANY ELI LILLY TO PAY RECORD
$1.415 BILLION FOR OFF-LABEL DRUG MARKETING
Criminal Penalty is Largest Individual Corporate Criminal Fine
PHILADELPHIA – United States Attorney General Michael B. Mukasey and Acting United States Attorney Laurie Magid today announced [...]
